Display Settings:

Format

Send to:

Choose Destination
    Br J Cancer. 2001 Jan 5;84(1):87-9.

    Selective cancer cell killing by alpha-tocopheryl succinate.

    Source

    Institute for Prevention of Cardiovascular Diseases, Ludwig Maximilians University, Pettenkoferstrasse 9, Munich, 80336, Germany.

    Abstract

    We report that alpha-tocopheryl succinate, a vitamin E analogue with pro-apoptotic properties, selectively kills cells with a malignant or transformed phenotype, i.e. multiple haematopoietic and carcinoma cell lines, while being non-toxic to normal, i.e. primary and non-transformed cells. These findings strongly suggest a potential of this micronutrient in the therapy and/or prevention of cancer without significant side-effects.

    Copyright 2001 Cancer Research Campaign.

    PMID:
    11139318
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2363620
    Free PMC Article

      Supplemental Content

      Icon for Nature Publishing Group Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk